Combination therapy with nivolumab and tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma.

被引：0
|
作者：
Garmezy, Benjamin
Zhang, Tian
Laccetti, Andrew Leonard
Economides, Minas P.
Shah, Amishi Yogesh
Tannir, Nizar M.
Jonasch, Eric
Msaouel, Pavlos
Zurita, Amado J.
Corn, Paul Gettys
Venkatesan, Aradhana M.
Brown, Landon Carter
Kao, Chester
Kinsey, Emily Noelle
Harrison, Michael Roger
Armstrong, Andrew J.
George, Daniel J.
Campbell, Matthew T.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Duke Canc Inst, Durham, NC USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17090
引用
收藏
页数：2
相关论文
共 50 条
  • [21] TiNivo: safety and efficacy of tivozanib-nivolumab combination therapy in patients with metastatic renal cell carcinoma
    Albiges, L.
    Barthelemy, P.
    Gross-Goupil, M.
    Negrier, S.
    Needle, M. N.
    Escudier, B.
    ANNALS OF ONCOLOGY, 2021, 32 (01) : 97 - 102
  • [22] Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?
    Ucar, Gokhan
    Acikgoz, Yusuf
    Ergun, Yakup
    Bal, Oznur
    Yilmaz, Mesut
    Karakaya, Serdar
    Akdeniz, Nadiye
    Kostek, Osman
    Isak, Ozlem Aydin
    Sener, Gorkem Yazici
    Dirikoc, Merve
    Esen, Selin Akturk
    Dogan, Mutlu
    Uncu, Dogan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [23] CXCR1 expression predicts benefit from tyrosine kinase inhibitors therapy in patients with metastatic renal cell carcinoma
    Chen, Xiang
    Liu, Li
    Wang, Jiajun
    Lin, Zhiyuan
    Xiong, Ying
    Qu, Yang
    Wang, Zewei
    Yang, Yuanfeng
    Guo, Jianming
    Xu, Jiejie
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (05) : 242.e15 - 242.e21
  • [24] Macrocytosis in patients with metastatic renal cell carcinoma (mRCC) treated with tyrosine kinase inhibitors (TKI's)
    Khasawneh, M. F.
    Unnithan, J.
    Choueiri, T.
    Rini, B.
    Dreicer, R.
    Garcia, J.
    Wood, L.
    Elson, P.
    Bukowski, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Prognostic significance of pseudocapsule status in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
    Xi, Wei
    Hou, Yingyong
    Hu, Xiaoyi
    Xia, Yu
    Jiang, Shuai
    Wang, Hang
    Bai, Qi
    Hou, Jun
    Guo, Jianming
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (11) : 4132 - +
  • [26] Then and now: The effect of tyrosine kinase inhibitors on survival in patients with metastatic renal cell carcinoma in Alberta, Canada
    Warren, M. A.
    Venner, P. M.
    North, S. A.
    Finch, D.
    Ghosh, S.
    Venner, A.
    Venner, C.
    Cheng, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [27] Prognostic Value of Hematologic Parameters in Patients with Metastatic Renal Cell Carcinoma Using Tyrosine Kinase Inhibitors
    Gunduz, Seyda
    Mutlu, Hasan
    Uysal, Mukremin
    Coskun, Hasan Senol
    Bozcuk, Hakan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (08) : 3801 - 3804
  • [28] SBRT and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma
    Onal, C.
    Oymak, E.
    Guler, O. C.
    Tilki, B.
    Yavas, G.
    Hurmuz, P.
    Yavas, C.
    Ozyigit, G.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1255 - S1255
  • [29] Efficacy and Safety of Lenvatinib in Combination With Other Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma A Meta-analysis
    Jamil, Abdur
    Qureshi, Zaheer
    Siddique, Rimsha
    Altaf, Faryal
    Akram, Hamzah
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2025, 48 (02): : 92 - 105
  • [30] Spine Stereotactic Radiosurgery With Concurrent Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma
    Miller, J. A.
    Balagamwala, E. H.
    Angelov, L.
    Suh, J. H.
    Rini, B.
    Garcia, J.
    Ahluwalia, M.
    Chao, S. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E95 - E96
12345